More Bad News For Novavax: A Citi Downgrade
December 19, 2017 at 09:48 AM EST
Novavax, Inc. (NASDAQ: NVAX), a small-cap clinical-stage vaccine company that focuses on therapies for both known and newly emerging ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.